Mission & Impact

Our Mission Statement: Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.

Results and Milestones

Numbers tell the story of our impact

Research and Education Funding
OCRA’s advocacy efforts have helped secure $3.8 billion in federal research and education funding: $3.8B
Invested in Science Innovation
$137M raised and invested in scientific breakthroughs: $137M
Individuals Helped Each Year
Our programs support more than 95,000 individuals annually: 95K

For each dollar we spend, 81 cents goes to funding critical research and innovative programs

Give now

Advancing Research and Fueling Hope

OCRA has both a laser focus and a panoramic view when it comes to the fight against gynecologic cancers.

Research

OCRA invests more funds into ovarian cancer research than any other public charity.

Advocacy

OCRA has built a team of passionate, dedicated advocates.

Patient Support

In times of adversity, support becomes a beacon of hope.

OCRA's History of Impact and Innovation

Ovarian Cancer Research Alliance (OCRA) is the oldest and largest ovarian and gynecologic cancer charity in the world. Since its founding in 1994, OCRA has grown into the leading non-government funder of ovarian and related gynecologic cancer research, investing over $137 million in groundbreaking studies. Through innovative education and advocacy efforts, compassionate support programs, and cross-industry collaboration, OCRA is driving progress and pushing the boundaries of what’s possible to improve outcomes for patients and advance research in its quest for a cure.

Learn about Liz Tilberis, OCRF’s first president